The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of abstinent days
Timeframe: Baseline to 3 months after treatment (analysis of all 3 primary outcomes via Win Ratio)
Change in WHO drinking levels by 1 or greater at month 3
Timeframe: Baseline to 3 months after treatment (analysis of all 3 primary outcomes via Win Ratio)
Phosphatidyl Ethanol (PEth) level change
Timeframe: Baseline to 3 months after treatment (analysis of all 3 primary outcomes via Win Ratio)